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1. SUMMARY 
The avirulent Salmonella typhimurium F885 was 
transformed with a plasmid carrying the cloned S 
fimbriae genes of a uropathogenic Escherichia coli. 
The resulting transformant (F885-1) produced ef-
ficiently E. coli S fimbriae and was used for live 
oral vaccination of rats. For comparison rats were 
immunized subcutaneously with isolated S 
fimbriae. Both routes of vaccination resulted in a 
significant lgG antibody response to S fimbriae. 
In addition live oral vaccination induced a serum 
lgA response against S fimbriae. After transure-
thral infection of rats with a S fimbriae producing 
E. coli a 10-fold reduction of bacterial counts in 
the kidney was observed in rats orally vaccinated 
with F885-1 as compared to unvaccinated con-
trols. This study suggests that the avirulent 
Salmonella F885 may be used as a fimbrial anti-
gen carrier for oral vaccination against renal infec-
tions. 
Correspondence to: Günter Schmidt, Forschungsinstitut Bors-
tel, Parkallee 1, 2061 Borstet, F.R.G. 
2. INTRODUCTION 
Escherichia coli is the causative agent in more 
than 80% of urinary tract infections. Uropatho-
genic strains of E. coli generally exhibit character-
istic virulence factors which enable the bacteria to 
adhere to urinary tract epithelial cells, toresist the 
bactericidal action of serum and to darnage 
eukaryotic cells by means of hemolysin [1). Ad-
herence to uroepithelial cells - the initial step in 
the infection process - is mediated by microbial 
adhesins which very often represent minor compo-
nents of fimbrial structures [2,3). Depending on 
their receptor structures, the adhesins are subdi-
vided into P, S, M, and X types [4,5]. The receptor 
for P fimbriae is the o-a-Gal-(1-4)-ß-o-Gal moiety 
of the P blood group antigens [ 6). P fimbriae are 
associated with the majority of uropathogenic 
strains. S fimbrial adhesins (Sfa) which interact 
with sialyl-(2-3) galactoside structures on human 
erythrocytes [7], are also present on uropathogenic 
strains and to a larger extent on strains isolated 
from cases of meningitis in the new-born [4]. M _ 
fimbriae require blood group M-specific determi-
nants of glycophorin-A as receptor [8). The so-
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called X adhesins recognize an unidentified recep-
tor on human red blood cells. In addi tion, the 
majority of E. coli isolates from different sources 
exhibit type I fimbriae which are able to recognize 
mannose-containing receptor structures [9]. 
In parenteral immunization experiments [10-12] 
it has been shown that anti-fimbrial antiborlies 
afforded protection against experimental ascend-
ing pyelonephritis in rats and primates. 
This raises the question whether the production 
of anti-fimbrial antiborlies could also be induced 
by oral vaccines which have several advantages 
over parenteral vaccines, including the ease of 
administration and Iack of adverse side-reactions. 
lt has been shown earlier (13,14] that efficient oral 
immunization is achieved with some avirulent 
Salmonella given as live vaccine. These avirulent 
Salmonel/ae stimulate the production of intestinal 
and serum antiborlies against surface antigens after 
oral application in mice due to their ability to 
colonize the small intestine over a certain period 
without producing any systemic infection [14). If 
these avirulent strains are able to express adhesive 
E. coli fimbriae it remains to be determined 
whether they also can induce antiborlies against 
these fimbriae. 
The avirulent S. typhimurium F885 used here is 
a Salmonella hybrid expressing the E. coli 08 
antigens instead of the Salmonella factors 04, 5, 12 
[14] and has proved tobe a strong immunogen in 
oral vaccination of mice. As fimbrial antigen, we 
have used the S fimbriae of E. coli 536 [15). The 
respective genetic determinants termed 'sfa' have 
been cloned into the vector pBR322, resulting in 
the recombinant plasmid pANN 801-4 [15], which 
we used for transformation experiments with 
Salmonella F885. 
3. MATERIALSAND METHODS 
3.1. Strains 
The strains used have previously been de-
scribed [14,15). E. co/i 536 is a uropathogenic wild 
type strain with the antigen 06: K15: H31 and 
produces S fimbriae (Sfa +), type I fimbriae and 
fimbriae which show similarities to P fimbriae but 
which Iack any receptor specificity (Prf, P related 
fimbriae; Hacker et al., in preparation}. The S 
fimbriae-producing E. coli K-12/pANN 801-4 
was obtained by transformation of E. coli K-12 
strain HB101 with the plasmid pANN801-4, 
which carries a 8.0 Kb DNA fragment encoding 
the fimbriae of E. co/i 536 [15]. Salmonella typhi-
murium F885 is a his + hybrid from a cross of the 
E. coli 08 donor Hfr59 and a S. thyphimurium 
recipient (bis-). The hybrid exhibits the E. co/i 08 
antigens instead of Salmonella 04, 5, 12 due to the 
introduction of the his-linked donor rfb genes 
determining the 0 antigen biosynthesis. The 
bacteria were grown on LB medium or agar. Mc-
Conkey agar was used for reisolation of bacteria 
from rat organs. 
3.2. Genetic procedures 
Plasmid D NA was isolated from E. coli K-
12jpANN801-4 as described previously [15]. For 
transformation of bacteria with the plasmid 
pANN801-4, a modified procedure as described 
by Lederberg and Cohen [16] was applied. 
3. 3. Sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) of fimbrial subunits 
Isolated fimbriae were disintegrated and run on 
slab gels as described previously [17]. 
3. 4. Isolation of fimbriae 
In order to avoid any contamination with the 
06-specific lipopolysaccharide, the S fimbriae used 
for vaccination and as test antigen were isolated 
from the recombinant E. co/i clone K-12/ 
pANN801-4 instead of from E. co/i 536. The 
fimbriae were isolated and purified by gradient 
ultracentrifugation as described previously [18]. 
Fimbriae of other strains used in SDS-PAGE were 
crude preparations without further purification. 
3. 5. Anima! infection model 
Fernale rats (Han Wist) weighing 180-200 g at 
the beginning of the experiment were used. They 
were kept in an air-conditioned animal house, fed 
with Altromin and water ad libitum. The rats were 
infected with 1.5 ml of an E. coli 536 suspension 
(5 X 107 cfu/ml) given via the urethra into the 
bladder. The bacteria were harvested from over-
night culture into PBS, centrifuged, suspended 
again in PBS and adjusted to the desired con-
centration. 
3. 6. I mmunization procedures 
For oral imrnunization, rats were given 5 ml of 
a bacterial suspension (10 9 cfujml) in PBS. In 
some experimentsoral dosing was repeated on the 
next day or completed by an intraperitoneal injec-
tion of 2 ml of live bacteria two weeks after the 
first oral dose. Another group of rats received 7 
subcutaneous (s.c.) injections of isolated S fimbrial 
proteins within a period of 10 days (250 p.g pro-
tein per kg per day). 
3. 7. Recovery and enumeration of vaccine bacteria 
from organs . 
At specified times after oral dosing, rats were 
killed and the small intestines and spleens were 
removed. The intestines were rinsed with 20 ml 
ice-cold saline in order to remove fecal contents 
and unadsorbed bacteria. The washed small in-
testines and the spleens were homogenized in ice-
cold saline with an MSE homogenizer. Aliquots of 
the homogenates were spread on XLD agar plates 
which were incubated for 18 h at 37 ° C. 
3.8. Infection studies 
Rats were challenged with E. coli 536 via the 
urethra one week after one oral dose of F885-l. 
In comparative studies, rats were infected 10 days 
after the last s.c. injection of isolated fimbriae. 
The rats were sacrificed 7 days after the infection 
and the kidneys were removed. Viable counts of 
bacteria were made from kidney homogenates on 
McConkey agar plates. 
3. 9. Determination of antibodies 
Blood was obtained by cardiac puncture at 
different intervals after immunization. The sera 
were stored at - 20 ° C. The antibody-content was 
measured by a cherniluminescence assay [19], 
which can briefly be summarized as follows: 
Polystyrol plastic balls (Precision plastic balls, 
Chicago) were coated with S fimbrial protein iso-
lated from E. coli K-12/pANNSOl-4. Goat anti-
rat lgG (heavy and light chain specific), and lgA 
(alpha chain specific) (Cappel, Organon Teknika 
F.R.G.) were labeled with luminol (Sigma, Munich, 
231 
F.R.G.). The plastic balls were incubated for 60 
min at room temperature with rat serum. The 
serum was diluted 1 : 20 in PBS 4N Tween. Un-
bound rat antiborlies were removed by washings 
in Tween and then incubated for 90 min with 
labeled anti-rat antibodies, which were diluted 
1 : 1000 in PBS 4N Tween. After removal of un-
bound antibodies, salinewas added and the chem-
iluminescence activity was determined in a 
luminometer (Berthold, F.R.G.) after addition of 
H 20 2• Antibody activity was expressed as relative 
light units. Sera of non-immunized rats served as 
controls (day 0 in Fig. 2). Each group of rats 
consisted of 10 animals. Antibody activities were 
determined in duplicate. 
4. RESULTS 
4.1. Characterization of fimbriated strains 
The avirulent Salmonella F885 was trans-
formed with the recombinant plasmid pANN801 
Fig. 1. SOS-PAGE of fimbrial subunits from different strains. 
Lanes: (1) Mr marker proteins; (2) Salmonella F885; (3) 
Salmonella, F885-1; (4) E. coli HB101/pANN801-4; (5) E. 
coli 536. 
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-4 isolated from E. coli K-12/pANN801-4. The 
resulting transformant F885-1, like the wild type 
E. coli 536, produced hemagglutination with 
bovine and human red blood cells and was ag-
glutinable with antiserum specific for S fimbriae 
of E. coli 536 (20]. 
As demonstrated with SOS-PAGE of disin-
tegrated fimbriae (see Fig. 1), the transformant 
F885-1 produces fimbrial sub-units identical in 
size (16.5 kDa) with those of E. coli 536 and of E. 
coli K-12/pANN801-4. The fimbriae of E. coli 
K-12/pANN801-4 were highly purified by CsCI 
gradient centrifugation and were used for s.c. vac-
cination and as test antigen for detecting S 
fimbriae antibodies. 
The other fimbrial preparations were .crude ex-
tracts still contaminated with various surface pro-
tein components. Thus the protein bands of about 
50000 kDa in I an es 2, 3 and 5 (Fig. 1) are flagellin 
proteins of Salmonella F885 and E. coli 536, 
respectively. The 22 kDa protein in lane 5 repre-
sents the protein subunits of the non-hemagg-
Table 1 
Salmonella colonization (mean log cfu/g of tissue ± standard 
deviation) of the intestines 1, 2, 6, 13, and 20 days after per 
oral administration of Salmonella typhimurium F 885-1 
Salmonella colonization on day 
1 
3.97 ±0.5 
(5/5) • 
2 
5.01 ±0.2 
(5/5) 
6 
3.97±0.7 
(5/5) 
13 
1.41 ±0.4 
(5/5) 
20 
1.16 ± 0.5 
(5/5) 
* number of culture positive animalsjnumber of animals 
tested. 
lutinating P related fimbriae (Prf) which are also 
associated with E. coli 536 [15]. 
4.2. Persistence of recombinant Salmonella strains 
in the small intestine 
lt has been shown that the ability of the F885 
bacteria to persist for nearly 20 days in the small 
intestine of mice after oral application is decisive 
for the immunogenic efficiency. We therefore ex-
amined how long F885-1 bacteria can persist in 
RLU •I 1 s.c. injections of S-fimbrial protein 
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Fig. 2. Antifimbrial antibodies in rat serum (median of 10 animals, range) determined by the chemiluminescence method and 
expressedas relative light units (RLU). Auows indicate vaccination. The upper group of curves represent IgG antibody activities, the 
lower group of curves represent lgA antibody response. •--• one oral administration: t::.--t::. two oral administrations; 
0--o two oral and one intraperitoneal administration of a suspension of Salmonella typhimurium F885-l, .,. __ .,. s.c. 
injections of S-fimbrial protein. The values of normal rat serum (median of 10 animals, range) are given at time zero. 
the rat small intestine after oral dosing. Five rats 
were sacrificed on day 1, 2, 6, 13, and 20 afteroral 
application of one dose consisting of 5 X 109 
bacteria of F885-l and the number of organisms 
associated with the gut epithelium was de-
termined. The results (Table 1) show that there is 
obviously a steady decline in the number of 
bacteria after day 2 but organisms were still de-
tected on day 20 after oral dosing. All animals 
tested bad Salmonella positive gut cultures. The 
spleens of the animals were, if at all, generally less 
colonized with vaccine bacteria. None of the orally 
vaccinated rats died. 
4.3. Anti S fimbriae antibody response 
The results of antibody determinations are pre-
sented in Fig. 2. One oral dose of Salmonella 
F885-l Ied to a 5-10-fold increase of serum anti-
fimbrial antibodies of the IgG class during the 
first week, indicating that S fimbriae were also 
produced in vivo. The antibody Ievels reached a 
peak 3 weeks after oral administration and then 
declined slightly. In addition, a two-fold increase 
of the level of anti-fimbrial lgA antiborlies was 
observed ( P < 0.05). Repeated oral immunization 
stimulated the IgG antibody production further 
but did not affect the IgA antibody response. An 
additional intraperitoneal injection after two oral 
doses led to a further increase of lgG antiborlies 
and provoked a slight but not significant stimulus 
of IgA antibody production. S fimbrial protein 
given subcutaneously seven times within 10 days 
caused a relatively greater increase of IgG anti-
hodies as compared to the effects of oral vaccina-
tion. However, in contrast to orally adrninistered 
vaccine no serum IgA antibody response could be 
detected after s.c. adrninistration of fimbrial pro-
teins. 
4.4. Jnfluence of vaccination on the growth rate of 
E. coli 536 in the kidney 
The experimental infection of untreated ratsvia 
the urethra with E. coli 536 led on day 7 p.i. to 
renal bacterial counts of more than 20000 cfu/g 
of kidney (Fig. 3). Five percent of the infected 
animals died. 
After active subcutaneous immunization with 
fimbrial proteins, the renal bacterial counts of the 
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Fig. 3. Nephropathogenicity in a rat pyelonephritis model of 
the S fimbriae-producing E. coli strain 536 after different 
immunization procedures. Bacterial counts/g of renal tissue 
were determined one week after transurethral infection. Statis-
tical evaluation: Significant differences ( P < 0.05) between the 
animals immunized with F885-l versus the non-immunized 
group. 
infectious E. coli 536 were reduced to less than 
5000 cfu/g of kidney. One oral dose of the live 
Salmonella F885-1 bad an even more pronounced 
protective activity as judged by the bacterial counts 
in the kidney after infection with E. coli 536. The 
lethality, however, which occurred within the first 
3 days after transurethral infection, was about 
20% in the group of rats vaccinated orally with 
live F885-l organisms, indicating that at the given 
time-point of infection the susceptibility of rats is 
even enhanced, in some animals, by this immuni-
zation procedure. 
5. DISCUSSION 
It has been demonstrated recently that E. coli S 
fimbrial adhesins contribute to nephropathogenic-
ity in a rat pyelonephritis model [1). Therefore, S 
fimbriae were chosen as the basis for vaccines 
used here for rat immunization studies. We have 
shown that cloned fimbrial genes of a uropatho-
genic E. coli are efficiently expressed in the aviru-
lent S. typhimurium F885-l. The oral administra-
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tion of the recombinant Salmonella strain F885-1 
producing E. coli S fimbriae Ieads to the produc-
tion of serum lgG and lgA antiborlies directed 
against these fimbriae. An increase in serum IgA 
antiborlies directed against S fimbriae was ob-
served only after oral dosing of a live vaccine but 
not after parenteral injection of isolated fimbriae. 
This may be explained by results obtained earlier 
with F885 in mice [14). These experiments have 
shown that the stimulation of serum and intestinal 
IgA antiborlies directed against surface antigens is 
feasible only by oral administration of bacteria 
like F885 which are able to colonize the small 
intestinal epithelium. 
U sing a similar approach, Stevenson and Man-
ning [21] employed a galactose-epimerase-defi-
cient (gal-) mutant of Salmonella typhimurium as 
carrier for the cloned E. coli K88 antigen, which is 
a colonization factor of enterotoxigenic E. coli. 
The oral administration of the resulting transfor-
mant led to high Ievels of IgG antiborlies directed 
against the K88 antigen both in serum and in the 
small intestine of mice. 
In a preliminary infection experiment with E. 
coli 536 in rats, the development of bacterial counts 
in the kidney after immunization by different pro-
cedures and of untreated controls was compared. 
The different ways of immunization applied were 
successful in stimulating the production of anti-
fimbrial antibodies. As demonstrated in Fig. 2, 
one oral dose of the live recombinant Sfa + 
Salmonella hybrid strain F885-1 is responsible for 
a 10-fold reduction of renal bacterial counts on 
day 7 aftertransurethral infection as compared to 
results with non-vaccinated controls. Similar re-
sults were obtained after multiple sucutaneous 
injections of fimbrial proteins. Therefore, it seems 
conceivable that the presence of serum anti-
fimbrial antiborlies produced by different irnmuni-
zation procedures in rats exerts a protective effect 
against urinary tract infections. This has also been 
shown recently in other animal infection models 
[10). 
Although a live oral vaccine seems to be attrac-
tive because of its ease of administration, the 
increase of lethality after infection with E. coli 
536 as a side-effect of oral live vaccination indi-
cates that this way of immunization may interfere 
with the antibacterial host defence mechanisms as 
has been shown in other studies. Thus, vaccination 
of mice with a live avirulent Salmonella mutant 
(aro -) led to marked suppression of the mitogenic 
responsiveness of spieen cells to E. coli and 
Salmonella lipopolysaccharide [22]. Similar effects 
were observed after vaccination with viable Bacil-
lus Calmette-Gm!rin [23). The appearance of sup-
pressor T-cells in the immune response to BCG, 
possibly induced by a feedback mechanism, may 
point to the possible role of suppressor cells in 
turning off the immune response [24] but as a 
side-effect may increase the infection suscept-
ibility. It will now be necessary to determine to 
what extent infection susceptibility depends on 
the time-point of challenge after oral vaccination 
with S. typhimurium F885. 
ACKNOWLEDGEMENTS 
This study was supported by the DFG (Ma 
864/2-2 and Ha 1434/1-5). 
REFERENCES 
[1] Marre, R., Hacker, J., Henkel, W .. and Goebel, W. (1986) 
Contribution of cloned virulence factors from uropatho-
genic Escherichia coli strains to nephropathogenicity in an 
experimental rat pyelonephritis model. Infect. Immun. 54, 
761-767. 
[2] Lund, B., Lindberg, F.P., Baga, M., Norrnark, S. (1985) 
Globoside specific adhesins of uropathogenic Escherichia 
coli are encoded by similar transcomplementable gene 
clusters. J. Bacteriol. 162, 1293-1301. 
[3] Moch, T., Hoschützky, H., Hacker, J., Ki-öncke, K.D., and 
Jann, K. (1987) Isolation arid characterization of the 
-sialyl·ß-2,3-galactosyl-specific adhesin from fimbriated 
Escherichia coli. Proc. Natl. Acad. Sei. U.S.A. 84, 
3462-3466. 
(4] Korhonen, T.K., Valtonen, M.V.. Parkkinen. J .. 
Väisänen-Rhen, V., Finne, J., 0rskov, F., 0rkov, 1., Sven-
son, S.B., and Mäkelä, P.H. (1985) Serotype, hemolysin 
production, and receptor recognition of Escherichia coli 
strains associated with neonatal sepsis and meningitis. 
lnfect. Immun. 48, 486-491. 
(5) Bock, K., Breimer, M.E., Brignole, A., Hansson, G.C., 
Karlsson, K.A., Larson, G., Leffler, H., Samuelsson, B.E., 
Strömberg, N., Svanborg-Eden, C., and Thurin, J. (1985) 
Specificity of binding of uropathogenic Escherichia coli to 
Gal-1-4-Gal containing glycosphingolipids. J. Biol. Chem. 
260, 8454-8551. 
[6] Svanborg-Eden, C., Hagberg, L., Hull, R., Hull, S., Lef-
fler, H., Lomberg, H., and Nilsson, B. (1986) Bacterial 
attachment to glycoconjugate receptors: Uropathogenic 
Escherichia coli. In Protein-carbohydrate interactions in 
biological systems. (Lark, D .• Normark; S., Wolf-Watz, H. 
and Uhlin, B.E. eds.), pp. 135-145, Academic Press, 
London. 
[7] Parkkinen, J., Rogers, G.N., Korhonen, T., Dahr, W., and 
Finne, J. (1986) Identification of the 0-linked sialyloligo-
saccharides of glycophorin as the erythrocyte receptors for 
S-fimbriated Escherichia co/i. lnfect. Immun. 54, 37-42. 
[8] Väisänen, V., Korhonen, T.K., Jokinen, M., Gah.mberg, 
C.G. and Ehnholm, C. (1982) Blood group M specific 
hemagglutinin in pyelonephritic Escherichia coli. Lancet. 
1192. 
[9] Ofek, 1., and Beachey, E.H. (1978) Mannose binding and 
epithelial cell adherence of Escherichia co/i. Infect. Im-
mun. 22, 247-248. 
[10] O'Hanley, P., Lark, D., Falkow, S., and Schoolnik, G. 
(1985) Molecular basis of Escherichia coli colonization of 
the upper urinary tract BALBjc mice. J. Clin. Invest. 75, 
347-360. 
[11] Silverblatt, F.J., and Cohen, L.S. (1979) Antipili antibody 
affords protection against experimental ascending 
pyelonephritis. J. Clin. lnvest. 64, 333-336. 
[12] Roberts, J.A., Hardaway, K., Kaack, B., Fussell, E.N., 
and Baskin, G. (1984) Prevention of pyelonephritis by 
immunization with P fimbriae. J. Urol. 131, 602-6p6. 
[13] Moser, 1., Hohrnann, A., Schmidt, G., and Rowley, D. 
(1980) Salmonellosis in mice: Studies on oral immuniza-
tion with live avirulent vaccines. Med. Microbiol. Im-
munol. 168, 119-128. 
[14) Hohmann, A., Schmidt, G., and Rowley, D. (1979) In-
testinal and serum antibody responses in mice after oral 
immunization with Salmonella, Escherichia co/i and 
Salmonella- Escherichia coli hybrid strains. lnfect. Im-
mun. 25, 27-33. 
[15] Hacker, J., Schmidt, G., Hughes, C., Knapp, S., Marget, 
M., and Goebel, W. (1985) Cloning and characterization 
235 
of genes involved in production of mannose-resistant, 
neuraminidase-susceptible (X) fimbriae from a uropatho-
genic 06: K15: H31 Escherichia coli strain. Infect. Immun. 
47, 434-440. 
[16] Lederberg, E.M., and Cohen, S.N. (1974) Transformation 
of Salmonella typhimurium by plasrnid deoxyribonucleic 
acid. J. Bacteriol.119,1072-1074. 
[17] Jann, K., Jann, B., and Schmidt, G. (1981) SOS poly-
acrylamide gel electrophoresis and serological analysis of 
pili from Escherichia coli from different pathogenic origin. 
FEMS Microbiol. Lett. 11, 21-25. 
[18] Wevers, P., Picken, R., Schmidt, G., Jann, B., Jann, K .• 
Golecki, J.R., and K.ist, M. (1980) Characterization of pili 
associated with Escherichia coli 018ac. lnfect Immun. 29. 
685-691. 
[19] Baumann, P., and Wood. W.G. (1985) Serum thyroglobu-
lin concentrations in the first weeks of life as measured 
with an immunoluminometric assay. J. Clin. Chem. Clin. 
Biochem. 23. 753-758. 
[20] Hacker, J., Schrettenbrunner, G .• Schröter, G., Schmidt, 
G., Düvel. H., and Goebel, W. (1986) Characterization of 
Escherichia coli wild type strains by means of agglutina-
tion with antisera raised against cloned P-, S-, and MS-
fimbriae antigens. hemagglutination, serotyping and he-
molysin production. Zbl. Bakt. Hyg. A 261, 219-231. 
[21] Stevenson, G .. and Manning, P.A. (1985) Galactose epi-
meraseless (galE) mutant G30 of Salmonella typhimurium 
is a good potential live oral vaccine carrier for fimbrial 
antigens. FEMS Microbiol. Lett. 28, 317-321. 
[22] Eisenstein, T.K.. Killar, L.M .• Stocker, B.A.D .• and Sultzer, 
B.M. (1984) Cellular immunity induced by avirulent 
Salmonella in LPS-defective C3HjHeJ mice. J. lmmunol. 
133. 958-961. 
[23] Turcotte, R., and Lemieux, S. (1982) Mechanisms of ac-
tion of Mycobacterium bovis BCG-induced suppressor cells 
in mitogen-induced blastogenesis. Infect. Immun. 36, 263. 
[24] Hahn, H .. and Kaufmann, St.H.E. (1981) The role of 
cell-mediated immunity in bacterial infections. Rev. In-
feet. Dis. 3, 1221-1250. 
